Joseph K. Belanoff, CEO: Corcept Therapeutics CORT Sell · Filed 25/04/02

Trade details

Type: Insider sale
Amount: $3,324,861.44
Shares · price: 35,102 sh · $94.72 a share
Held after: 2,982,335 sh
Stock: Corcept Therapeutics CORT
Person: Joseph K. BelanoffCEO
Trade date: 25/03/31
Filed: 25/04/02
Days to filing: 2 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Joseph K. Belanoff's recent trades

Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$895.3K
12,837 sh
$895.3K
Filed 06/02
Traded 06/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$892K
12,837 sh
$892K
Filed 06/01
Traded 06/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$2M
40,000 sh
$2M
Filed 05/05
Traded 05/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
40,000 sh
$1.9M
Filed 05/01
Traded 05/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.3M
26,198 sh
$1.3M
Filed 03/27
Traded 03/25